Compare Cigna Corp (CI) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Williams-Sonoma, Inc. — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Williams-Sonoma, Inc. trades at $250.52 (market cap $29.53B). The key difference: Cigna Corp is far larger — about 2.5× Williams-Sonoma, Inc.'s market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | WSM | |
|---|---|---|
Market Cap | $73.56B | $29.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $251.81 |
52-Week Low | $244.41 | $168.64 |
Enterprise Value | $98.27B | $30.38B |
Dividend Yield | 2.24% | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Williams-Sonoma (WSM) trades at $251.81, up 1.94% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate overbought conditions. Fundamentally, the company maintains robust profitability with a 13.81% net income margin and has beaten earnings estimates for three consecutive quarters. A dividend of $0.76 is scheduled for payment in August 2026, reflecting shareholder returns.
WSM's outlook is supported by consistent earnings outperformance and high profitability metrics like 54.01% ROE. However, valuation multiples such as a P/E of 28.23 appear elevated relative to historical norms. Key risks include consumer discretionary spending volatility and competitive pressures in home furnishings. Analyst consensus is mixed with a $222.22 price target below the current price, suggesting cautious optimism amid rich valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
